Ximing joined the Pureos Bioventures team in 2018. Prior to Pureos, he was Post-doc at the European Molecular Biology Laboratory in Heidelberg, Germany. As an Associate, Ximing is active in deal flow generation, investment due diligence, investment and exit transactions as well as fundraising support. Ximing is currently a BoD observer at Araris Biotech. Ximing obtained his PhD at the European Molecular Biology Laboratory and holds an MSc. in Biology at ETH Zurich.
Current role